Edwards Lifesciences provides products and technologies for structural heart disease and critical care monitoring globally. Products include transcatheter heart valves and surgical valve solutions. Critical care solutions include hemodynamic monitoring systems and a monitoring platform. The company also offers software to predict hypotension and alert clinicians. Products are distributed through a direct sales force and independent distributors. Founded in 1958, Edwards Lifesciences is headquartered in Irvine, California.
Indicator | Value |
---|---|
PER | 10.8 |
EV/EBITDA | 24.2 |
Price/Free Cash Flow' | 173.2 |
ROIC | 5.1% |
Net Debt/EBITDA | -1.3 |